tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Pasquale, 7 are a HOLD (28%), 18 are a BUY (72%).
Analyst Christopher Pasquale, currently employed carries an average stock price target met ratio of 59.85% that have a potential upside of 19.56% achieved within 137 days.
Christopher Pasquale’s has documented 45 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PRCT, Procept Biorobotics Corp at 09-Mar-2022.
Analyst best performing recommendations are on PRCT (PROCEPT BIOROBOTICS CORP).
The best stock recommendation documented was for PRCT (PROCEPT BIOROBOTICS CORP) at 10/11/2021. The price target of $45 was fulfilled within 2 days with a profit of $3.45 (8.3%) receiving and performance score of 41.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
90
$20.66 (29.80%)
90
5 days ago
18/28 (64.29%)
$16.33 (22.17%)
121
Buy
100
$30.66 (44.22%)
90
8 days ago
10/15 (66.67%)
$25.93 (35.01%)
216
Hold
82
$12.66 (18.26%)
80
26 days ago
15/19 (78.95%)
$9.57 (13.21%)
250
Hold
113
$43.66 (62.97%)
138
1 months 2 days ago
4/5 (80%)
$45.52 (67.46%)
75
Buy
115
$45.66 (65.85%)
150
1 months 5 days ago
19/22 (86.36%)
$51 (79.69%)
84
What Year was the first public recommendation made by Christopher Pasquale?
